Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

496 Press Releases
DateTitleCompany
23 Jul 12 Pfizer Reports Top-Line Results of EU Post-Authorization Safety and Efficacy Study of Lyrica’s Discontinuation Effects In Patients with Generalized Anxiety Disorder Pfizer Inc.,
Published by
Business Wire
23 Jul 12 Pfizer Reports Top-Line Results of Study of Lyrica’s Effect on Male Reproduction Conducted as a Post-Approval Commitment Required by the U.S. Food and Drug Administration Pfizer Inc.,
Published by
Business Wire
20 Jul 12 Pfizer’s Crizotinib Receives Positive Opinion For Conditional Marketing Authorization From The Committee For Medicinal Products For Human Use For The Treatment Of Adults With Previously Treated ALK-Positive Advanced Non-Small Cell Lung Cancer In The EU Pfizer,
Published by
Business Wire
20 Jul 12 Pfizer and Northwestern University Win LYRICA® Patent Case in Delaware District Court Pfizer Inc.,
Published by
Business Wire
19 Jul 12 European Medicines Agency Accepts Regulatory Submission For Bazedoxifene/Conjugated Estrogens For The Treatment Of Symptoms Associated With Menopause And Osteoporosis Pfizer Inc.,
Published by
Business Wire
09 Jul 12 Inspra (eplerenone) accepted for use within NHS Scotland Pfizer
29 Jun 12 Pfizer Declares A 22-Cent Third-Quarter 2012 Dividend Pfizer Inc.,
Published by
Business Wire
26 Jun 12 Pfizer Invites Public to View and Listen to Webcast of July 31 Conference Call with Analysts Pfizer Inc.,
Published by
Business Wire
25 Jun 12 Bristol-Myers Squibb and Pfizer Receive Complete Response Letter from U.S. Food and Drug Administration for ELIQUIS® (apixaban) Pfizer Inc.,
Published by
Business Wire
22 Jun 12 REAL-WORLD DATA REINFORCE CLINICAL EFFICACY OF XIAPEX® IN THE TREATMENT OF DUPUYTREN’S CONTRACTURE Pfizer
21 Jun 12 FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review Pfizer Inc.,
Published by
Business Wire
20 Jun 12 Pfizer Statement Regarding Prevnar 13® Receiving ACIP Recommendation for Prevention of Pneumococcal Disease in Adults With Immunocompromising Conditions Pfizer Inc,
Published by
Business Wire
19 Jun 12 Pfizer Announces Positive Results From Phase 3 Study PROFILE 1007 Evaluating XALKORI® (crizotinib) In Previously Treated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
19 Jun 12 FDA Issues Complete Response Letter For Pfizer’s Tafamidis Meglumine New Drug Application Pfizer Inc.,
Published by
Business Wire
18 Jun 12 Have Americans Reached a New Era of Optimism about Aging? Pfizer,
Published by
Business Wire
31 May 12 INTERACTIVE VIDEO ALLOWS VIEWERS TO EXPERIENCE IMPACT OF DUPUYTREN’S DISEASE Pfizer
28 May 12 One in four cases of invasive pneumococcal disease in adult risk groups prove fatal Pfizer
25 May 12 Pfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EU Pfizer,
Published by
Business Wire
25 May 12 FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer’s Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) Pfizer Inc.,
Published by
Business Wire
23 May 12 Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units Pfizer Inc.,
Published by
Business Wire
22 May 12 Pfizer Invites Public to View and Listen to Webcast of June 3 Pfizer Analyst and Investor Meeting at ASCO Pfizer Inc.,
Published by
Business Wire
22 May 12 New European guidelines set to benefit heart failure patients in the UK Pfizer
21 May 12 SMC recommends XIAPEX®q (Collagenase Clostridium Histolyticum) for NHS use Pfizer,
Published by
Red Consultancy
18 May 12 Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients Pfizer Inc.,
Published by
Business Wire
16 May 12 Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC) Pfizer Inc,
Published by
Business Wire
14 May 12 Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting Pfizer,
Published by
Business Wire
10 May 12 FDA Arthritis Advisory Committee Recommends Approval of Tofacitinib for Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Pfizer Inc.,
Published by
Business Wire
09 May 12 New for pharmacists: online COPD resource at the click of a button Boehringer Ingelheim Ltd and Pfizer Ltd,
Published by
Porter Novelli
07 May 12 Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ® (desvenlafaxine) 50 mg/day For The Treatment Of Major Depressive Disorder In Adults Pfizer Inc.,
Published by
Business Wire
04 May 12 Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy Pfizer Inc.,
Published by
Business Wire
Advertising